alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 99.7



CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002



In connection with the annual report of
Exeter Resource Corporation (the “Company”) on Form 40-F for the period ended December 31, 2011 as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Cecil Bond, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



(1)         The
Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)         The
information contained in this Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.



| | March 30, 2012 | /s/ Cecil Bond                              
| | -------------- | --------------------------------------------
| |                |                                             
| |                | Cecil Bond                                  
| |                | Chief Financial Officer                     
| |                | (Principal Financial and Accounting Officer)
exv10w8



 





Exhibit
10.8




Non-employee
Director Compensation Program

Effective January 1, 2008




Cash Fees




	 	 	 	 	 	 	 	 	 
	 	 	Member	 	 	Chairman	 
	 	 	Annual Fee	 	 	Annual Fee	 
	Board of Directors
	 	$	35,000	 	 	$	60,000	 
	Audit Committee
	 	$	7,000	 	 	$	15,000	 
	Compensation Committee
	 	$	5,000	 	 	$	10,000	 
	Nominating and Corporate Governance Committee
	 	$	3,500	 	 	$	7,500	 






Equity Fees




     Each
new non-employee director will receive an option to purchase 16,000 shares of the Company’s Common
Stock at the fair market value on the date of grant, and each ongoing director will receive an
annual grant following the annual meeting to purchase 10,000 shares of the Company’s Common Stock
at the fair market value of the Common Stock on the date of grant. All options under the director
compensation program will vest quarterly over three years.



     Effective,
January 2, 2008, all currently serving non-employee directors will receive an option to purchase
16,000 shares of the Company’s common stock at an exercise price equal to the closing price of the
Company’s Common Stock on the NASDAQ Global Market on January 2, 2008. All options will vest
quarterly over three years.
II 

112TH CONGRESS 

2D SESSION S. 3029 

To extend the temporary suspension of duty on ion-exchange resins consisting 

of copolymers of acrylic acid and diethylene glycol divinyl ether. 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2012 

Mr. LAUTENBERG introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on ion-exchange 

resins consisting of copolymers of acrylic acid and 

diethylene glycol divinyl ether. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ION-EXCHANGE RESINS CONSISTING OF CO4 POLYMERS OF ACRYLIC ACID AND 

5 DIETHYLENE GLYCOL DIVINYL ETHER. 

6 (a) IN GENERAL.—Heading 9902.11.71 of the Har7 monized Tariff Schedule of the United States (relating to 

8 ion-exchange resins consisting of copolymers of acrylic 

9 acid and diethylene glycol divinyl ether) is amended by 


tjames on DSK6SPTVN1PROD with BILLS
2 

•S 3029 IS

1 striking the date in the effective period column and insert2 ing ‘‘12/31/2015’’. 

3 (b) EFFECTIVE DATE.—The amendment made by 

4 subsection (a) applies with respect to goods entered, or 

5 withdrawn from warehouse for consumption, on or after 

6 the 15th day after the date of the enactment of this Act. 

Æ 


tjames on DSK6SPTVN1PROD with BILLS
[Federal Register Volume 74, Number 75 (Tuesday, April 21, 2009)]
[Notices]
[Pages 18243-18244]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-9133]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract

[[Page 18244]]

proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel. Review for Registry and Surveillance System 
in Hemoglobinopathies (RuSH) Pilot Studies.
    Date: May 11, 2009.
    Time: 9:30 a.m. to 2 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Telephone Conference Call).
    Contact Person: William J Johnson, PhD, Scientific Review 
Officer, Review Branch/DERA, National Heart, Lung, and Blood 
Institute, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892-7924. 
301-435-0725. <a href="/cdn-cgi/l/email-protection#751f1a1d1b061a1b021f351b1d19171c5b1b1c1d5b121a03"><span class="__cf_email__" data-cfemail="42282d2a2c312d2c3528022c2a2e202b6c2c2b2a6c252d34">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)


    Dated: April 15, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-9133 Filed 4-20-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
WP Exhibit 10.14  (00167806.DOC;1)


Exhibit 10.14







Wausau Paper Corp.

2007 Equity Incentive Compensation Plan




An individual officer’s grant at each tier will vest upon the Company’s achievement of targeted levels of return on capital employed for such tier and, with respect to the restricted stock units, the satisfaction of minimum service criteria.  The maximum potential award for the CEO, CFO, and each of the named executive officers is the cumulative award payable under each of Tiers I, II, and III.




						
	Tier I

	 	Tier II

	 	Tier III

	 
	Restricted stock units equal

	Options (100 shares 

	Options (100 shares 


	to 12% of base salary(1)

	per $2,000 base salary)(2)

	per $2,000 base salary)(2)







(1) Number of shares determined by closing price of Company stock ($14.99) on last business day preceding grant as markets were closed on date of grant.

(2) Exercise price of $14.99 per share (closing price of Company stock on last business day preceding grant as markets were closed on date of grant).
[Federal Register Volume 74, Number 74 (Monday, April 20, 2009)]
[Notices]
[Page 17994]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-8942]


-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Employment and Training Administration

[TA-W-65,645]


Ultimizers, Inc., Boring, OR; Notice of Termination of 
Investigation

    Pursuant to Section 221 of the Trade Act of 1974, as amended, an 
investigation was initiated on March 20, 2009 in response to a worker 
petition filed by a company official on behalf of workers of 
Ultimizers, Inc., Boring, Oregon.
    The petitioner has requested that the petition be withdrawn. 
Consequently, the investigation has been terminated.

    Signed at Washington, DC, this 26th day of March 2009.
Richard Church,
Certifying Officer, Division of Trade Adjustment Assistance.
[FR Doc. E9-8942 Filed 4-17-09; 8:45 am]
BILLING CODE 4510-FN-P
##### 



Exhibit 31.1Section 302 Certification I, Ellen Z. Lamale, certify that: I have reviewed this annual report on Form 10-K, and all reports on Form 8-K containing
distribution or servicing reports filed in respect of period included in the year covered by
this annual report, of Principal Life Income Fundings Trust 2004-58;  1.
    Based on my knowledge, the information in these reports, taken as a whole, does not contain
any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not
misleading as of the last day of the period covered by this annual report;  2.
    Based on my knowledge, the distribution or servicing information required to be provided to
the depositor by the trustee under the pooling and servicing, or similar agreement, for
inclusion in these reports is included in these reports;  3.
    I am responsible for reviewing the activities performed by the depositor and the trustee
under the pooling and servicing, or similar agreement, and based upon my knowledge and the
annual compliance review required under that agreement, and except as disclosed in the
reports, the depositor and trustee have each fulfilled its obligations under that agreement;
and  4.
    The reports disclose all significant deficiencies relating to the compliance by the trustee
and the depositor with the minimum servicing or similar standards based upon the report
provided by an independent public accountant, after conducting a review in compliance with the
Uniform Single Attestation Program for Mortgage Bankers or similar procedures, as set forth in
the pooling and servicing, or similar agreements, that is included in these reports. In giving the certifications above, I have reasonably relied on information provided to me by the
following unaffiliated parties: Ernst and Young and Citibank, N.A. Date: March 29, 2005 By:        /s/ Ellen Z. Lamale
Name:  Ellen Z. Lamale
Title:    Senior Vice President and Chief Actuary
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2793 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2793

    To suspend temporarily the duty on copper peptide (GHK-Cu 1:1).

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

Mr. Blumenthal introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
    To suspend temporarily the duty on copper peptide (GHK-Cu 1:1).

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. COPPER PEPTIDE (GHK-CU 1:1).

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00        Copper peptide      Free            No change      No change      On or before     ''.
                          (GHK-Cu 1:1) (CAS                                                 12/31/2015
                          No. 49557-75-7)
                          (provided for in
                          subheading
                          2933.29.90)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
II 

112TH CONGRESS 

2D SESSION S. 2803 

To suspend temporarily the duty on butanamide, N-(2,3-dihydro-2-oxo-1Hbenzimidazol-5-yl)-2-[2-(2-methoxyphenyl)diazenyl]-3-oxo-. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. KERRY introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the duty on butanamide, N-(2,3- 

dihydro-2-oxo-1H-benzimidazol-5-yl)-2-[2-(2- 

methoxyphenyl)diazenyl]-3-oxo-. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. BUTANAMIDE, N-(2,3-DIHYDRO-2-OXO-1H4 BENZIMIDAZOL-5-YL)-2-[2-(2- 

5 METHOXYPHENYL)DIAZENYL]-3-OXO-. 

6 (a) IN GENERAL.—Subchapter II of chapter 99 of 

7 the Harmonized Tariff Schedule of the United States is 

8 amended by inserting in numerical sequence the following 

9 new heading: 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•S 2803 IS

‘‘ 9902.01.00 Butanamide, N-(2,3-dihydro2-oxo-1H-benzimidazol-5-yl)- 

2-[2-(2- 

methoxyphenyl)diazenyl]-3- 

oxo- (CAS No. 82199–12–0) 

(provided for in subheading 

3204.17.60) ........................... Free No change No change On or before 

12/31/2015 ’’. 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
     This schedule  contains summary  financial  information  extracted from the
financial  statements of Ray Ellison Mortgage  Acceptance Corp. at September 30,
1997 and is qualified in its entirety by reference to such financial statements.
</LEGEND>
<CIK>                         754591
<NAME>                        Ray Ellison Mortgage Acceptance Corp.
<MULTIPLIER>                  1
<CURRENCY>                    Dollar
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>               DEC-31-1997
<PERIOD-START>                  JUL-01-1997
<PERIOD-END>                    SEP-30-1997
<EXCHANGE-RATE>                 1
<CASH>                          27,872
<SECURITIES>                    405,287,788
<RECEIVABLES>                   2,428,814
<ALLOWANCES>                    0
<INVENTORY>                     0
<CURRENT-ASSETS>                2,456,686
<PP&E>                          0
<DEPRECIATION>                  0
<TOTAL-ASSETS>                  426,096,667
<CURRENT-LIABILITIES>           2,431,526
<BONDS>                         402,659,000
<PREFERRED-MANDATORY>           0
<PREFERRED>                     0
<COMMON>                        10,000
<OTHER-SE>                      16,136,384
<TOTAL-LIABILITY-AND-EQUITY>    426,096,667
<SALES>                         0
<TOTAL-REVENUES>                7,475,545
<CGS>                           0
<TOTAL-COSTS>                   7,873,878
<OTHER-EXPENSES>                69,952
<LOSS-PROVISION>                0
<INTEREST-EXPENSE>              7,338,266
<INCOME-PRETAX>                 70,326
<INCOME-TAX>                    21,725
<INCOME-CONTINUING>             48,601
<DISCONTINUED>                  0
<EXTRAORDINARY>                 0
<CHANGES>                       0
<NET-INCOME>                    48,601
<EPS-PRIMARY>                   4.86
<EPS-DILUTED>                   4.86
        

</TABLE>
**Exhibit
32**





CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002











Each of
the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Quarterly
Report on Form 10-Q for the quarter ended March 31, 2005 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,
as amended, and the information contained in such report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.





This 16th
day of May, 2005








/s/
David D. Stovall


Chief
Executive Officer








/s/
Annette Banks


Chief
Financial Officer
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2879 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2879

  To renew the temporary suspension of duty on vulcanized rubber felt-
             bottom boots for actual use in fishing waders.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

  Mr. Baucus introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To renew the temporary suspension of duty on vulcanized rubber felt-
             bottom boots for actual use in fishing waders.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. VULCANIZED RUBBER FELT-BOTTOM BOOTS FOR ACTUAL USE IN 
              FISHING WADERS.

    (a) In General.--Heading 9902.23.84 of the Harmonized Tariff 
Schedule of the United States (relating to vulcanized rubber felt-
bottom boots for actual use in fishing waders) is amended by striking 
the date in the effective period column and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 15-10634

Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

JULIAN SANDOVAL-TORRES,

Defendant-Appellant

Appeal from the United States District Court

for the Northern District of Texas

USDC No. 4:15-CR-6-1

Before JONES, CLEMENT, and OWEN, Circuit Judges.

PER CURIAM:*

The Federal Public Defender appointed to represent Julian SandovalTorres has moved for leave to withdraw and has filed a brief in accordance with 

Anders v. California, 386 U.S. 738 (1967), and United States v. Flores, 632 F.3d 

229 (5th Cir. 2011). Sandoval-Torres has not filed a response. We have 

reviewed counsel’s brief and the relevant portions of the record reflected 

therein. We concur with counsel’s assessment that the appeal presents no 

 

* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not 

be published and is not precedent except under the limited circumstances set forth in 5TH 

CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

June 21, 2016

Lyle W. Cayce

Clerk

 Case: 15-10634 Document: 00513555648 Page: 1 Date Filed: 06/21/2016
No. 15-10634

2

nonfrivolous issue for appellate review. Accordingly, counsel’s motion for leave 

to withdraw is GRANTED, counsel is excused from further responsibilities 

herein, and the APPEAL IS DISMISSED. See 5TH CIR. R. 42.2.

 Case: 15-10634 Document: 00513555648 Page: 2 Date Filed: 06/21/2016
II 

112TH CONGRESS 

2D SESSION S. 3008 

To reduce temporarily the duty on product mixtures containing Clothianidin 

and Bacillus Firmus. 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2012 

Mr. MENENDEZ introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To reduce temporarily the duty on product mixtures 

containing Clothianidin and Bacillus Firmus. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PRODUCT MIXTURES CONTAINING 

4 CLOTHIANIDIN AND BACILLUS FIRMUS. 

5 (a) IN GENERAL.—Subchapter II of chapter 99 of 

6 the Harmonized Tariff Schedule of the United States is 

7 amended by inserting in numerical sequence the following 

8 new heading: 


srobinson on DSK4SPTVN1PROD with BILLS
2 

•S 3008 IS

‘‘ 9902.01.00 Product mixtures containing 

Clothianidin: (E)-N-[(2- 

chloro-1,3-thiazol-5- 

yl)methyl]-N-methyl 

[oxido(oxo)hydrazono] 

methanediamine or N-[(2- 

chloro-1,3-thiazol-5-yl) methyl]-N-{(E)-(methylamino) 

[oxido(oxo) 

hydrazono]methyl}amine 

(CAS No. 210880–92–5), 

and Bacillus Firmus: BAFI 

I-1582 (provided for in subheading 3808.91.50) ............. 4.2% No change No change On or before 

12/31/2015 ’’. 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


srobinson on DSK4SPTVN1PROD with BILLS
CERTIFICATION OF PERIODIC REPORT

Exhibit 32.1

I, Howard C.
Bluver, President & Chief Executive Officer of Suffolk Bancorp (the Company), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that: (1) the Quarterly Report on Form 10-Q
of the Company for the quarterly period ended March 31, 2012 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and (2) the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                                   
|-----------------------------------
|Dated: May 10, 2012                
|                                   
|/s/ Howard C. Bluver               
|Howard C. Bluver                   
|President & Chief Executive Officer
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 3144 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 3144

  To suspend temporarily the duty on preparations intended to assist 
                        smokers to stop smoking.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 10, 2012

  Mrs. Hagan introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To suspend temporarily the duty on preparations intended to assist 
                        smokers to stop smoking.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PREPARATIONS INTENDED TO ASSIST SMOKERS TO STOP SMOKING.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Preparations, such  Free         No change        No change        On or before 12/  ''.
                        as tablets,                                                        31/2015.......
                        chewing gum or
                        patches
                        (transdermal
                        systems),
                        intended to
                        assist smokers to
                        stop smoking
                        (provided for in
                        subheading
                        2106.90.99)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```